Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) Short Interest Update

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totaling 52,650 shares, a growth of 1,991.8% from the March 31st total of 2,517 shares. Based on an average trading volume of 42,451 shares, the days-to-cover ratio is presently 1.2 days.

Rocket Pharmaceuticals Price Performance

RCKTW stock remained flat at $0.01 during midday trading on Friday. 20,000 shares of the company’s stock were exchanged, compared to its average volume of 25,241. The firm has a 50 day moving average price of $0.02 and a 200-day moving average price of $0.02. Rocket Pharmaceuticals has a 1-year low of $0.01 and a 1-year high of $0.09.

Rocket Pharmaceuticals Company Profile

Rocket Pharmaceuticals, Inc is a clinical-stage biotechnology company focused on developing and commercializing novel, life-transforming gene therapies for rare pediatric diseases. The company’s research and development activities center on inherited genetic disorders, leveraging both lentiviral and adeno-associated virus (AAV) platforms to deliver corrective genes. Rocket’s lead programs include treatments for conditions such as Fanconi anemia, leukocyte adhesion deficiency-I (LAD-I), Danon disease and mucopolysaccharidosis type IIIA (MPS IIIA), each of which represents a high unmet medical need in the pediatric population.

Founded in 2015, Rocket Pharmaceuticals went public in 2018 and trades on the Nasdaq under the ticker symbol RCKTW.